JP4454114B2 - 超音波治療装置 - Google Patents
超音波治療装置 Download PDFInfo
- Publication number
- JP4454114B2 JP4454114B2 JP2000203058A JP2000203058A JP4454114B2 JP 4454114 B2 JP4454114 B2 JP 4454114B2 JP 2000203058 A JP2000203058 A JP 2000203058A JP 2000203058 A JP2000203058 A JP 2000203058A JP 4454114 B2 JP4454114 B2 JP 4454114B2
- Authority
- JP
- Japan
- Prior art keywords
- ultrasonic
- fluid
- treatment
- catheter
- irradiation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000002560 therapeutic procedure Methods 0.000 title claims description 19
- 239000012530 fluid Substances 0.000 claims description 112
- 238000003384 imaging method Methods 0.000 claims description 24
- 230000001225 therapeutic effect Effects 0.000 claims description 24
- 239000000126 substance Substances 0.000 claims description 23
- 230000008859 change Effects 0.000 claims description 15
- 238000009210 therapy by ultrasound Methods 0.000 claims description 9
- 238000009826 distribution Methods 0.000 claims description 8
- 238000001514 detection method Methods 0.000 claims description 7
- 230000001678 irradiating effect Effects 0.000 claims description 7
- 238000010438 heat treatment Methods 0.000 claims description 5
- 230000001112 coagulating effect Effects 0.000 claims description 3
- 239000003814 drug Substances 0.000 description 48
- 210000001519 tissue Anatomy 0.000 description 42
- 229940079593 drug Drugs 0.000 description 37
- 210000002307 prostate Anatomy 0.000 description 28
- 210000003708 urethra Anatomy 0.000 description 25
- 239000007789 gas Substances 0.000 description 19
- 230000009471 action Effects 0.000 description 18
- 238000002604 ultrasonography Methods 0.000 description 17
- 230000000694 effects Effects 0.000 description 16
- 239000007924 injection Substances 0.000 description 14
- 238000002347 injection Methods 0.000 description 14
- 238000000034 method Methods 0.000 description 14
- 239000000523 sample Substances 0.000 description 14
- 239000002826 coolant Substances 0.000 description 12
- 238000010521 absorption reaction Methods 0.000 description 11
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 10
- 230000005540 biological transmission Effects 0.000 description 10
- 201000007270 liver cancer Diseases 0.000 description 10
- 208000014018 liver neoplasm Diseases 0.000 description 10
- 238000002156 mixing Methods 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 description 8
- 208000004403 Prostatic Hyperplasia Diseases 0.000 description 8
- 239000002504 physiological saline solution Substances 0.000 description 8
- 210000003240 portal vein Anatomy 0.000 description 7
- 206010028980 Neoplasm Diseases 0.000 description 6
- 230000015271 coagulation Effects 0.000 description 6
- 238000005345 coagulation Methods 0.000 description 6
- 230000007246 mechanism Effects 0.000 description 6
- 206010060862 Prostate cancer Diseases 0.000 description 5
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 5
- 229910002092 carbon dioxide Inorganic materials 0.000 description 5
- 239000001569 carbon dioxide Substances 0.000 description 5
- 238000010586 diagram Methods 0.000 description 5
- 230000012010 growth Effects 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 230000002265 prevention Effects 0.000 description 5
- 150000003732 xanthenes Chemical class 0.000 description 5
- 239000003570 air Substances 0.000 description 4
- 210000001367 artery Anatomy 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 238000011049 filling Methods 0.000 description 4
- 230000007274 generation of a signal involved in cell-cell signaling Effects 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 150000004033 porphyrin derivatives Chemical class 0.000 description 4
- 210000000664 rectum Anatomy 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 3
- 239000007853 buffer solution Substances 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 230000007850 degeneration Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000020169 heat generation Effects 0.000 description 3
- 210000004877 mucosa Anatomy 0.000 description 3
- 230000010412 perfusion Effects 0.000 description 3
- 238000001959 radiotherapy Methods 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 230000000087 stabilizing effect Effects 0.000 description 3
- 230000002792 vascular Effects 0.000 description 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 102000009123 Fibrin Human genes 0.000 description 2
- 108010073385 Fibrin Proteins 0.000 description 2
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 206010020843 Hyperthermia Diseases 0.000 description 2
- 235000008753 Papaver somniferum Nutrition 0.000 description 2
- 240000001090 Papaver somniferum Species 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000031018 biological processes and functions Effects 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- 229950003499 fibrin Drugs 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 210000002767 hepatic artery Anatomy 0.000 description 2
- 230000036031 hyperthermia Effects 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- 229920000126 latex Polymers 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 210000001365 lymphatic vessel Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000008155 medical solution Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 201000004240 prostatic hypertrophy Diseases 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 229920002379 silicone rubber Polymers 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- IICCLYANAQEHCI-UHFFFAOYSA-N 4,5,6,7-tetrachloro-3',6'-dihydroxy-2',4',5',7'-tetraiodospiro[2-benzofuran-3,9'-xanthene]-1-one Chemical compound O1C(=O)C(C(=C(Cl)C(Cl)=C2Cl)Cl)=C2C21C1=CC(I)=C(O)C(I)=C1OC1=C(I)C(O)=C(I)C=C21 IICCLYANAQEHCI-UHFFFAOYSA-N 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 206010021639 Incontinence Diseases 0.000 description 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
- 206010051077 Post procedural haemorrhage Diseases 0.000 description 1
- 206010067268 Post procedural infection Diseases 0.000 description 1
- 206010071229 Procedural haemorrhage Diseases 0.000 description 1
- 206010051482 Prostatomegaly Diseases 0.000 description 1
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 1
- 206010046555 Urinary retention Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000004397 blinking Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000002648 combination therapy Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000002961 echo contrast media Substances 0.000 description 1
- 230000002828 effect on organs or tissue Effects 0.000 description 1
- IINNWAYUJNWZRM-UHFFFAOYSA-L erythrosin B Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=C(I)C(=O)C(I)=C2OC2=C(I)C([O-])=C(I)C=C21 IINNWAYUJNWZRM-UHFFFAOYSA-L 0.000 description 1
- 229940011411 erythrosine Drugs 0.000 description 1
- 235000012732 erythrosine Nutrition 0.000 description 1
- 239000004174 erythrosine Substances 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000012847 fine chemical Substances 0.000 description 1
- 238000002594 fluoroscopy Methods 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000003505 heat denaturation Methods 0.000 description 1
- 210000005161 hepatic lobe Anatomy 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000007769 metal material Substances 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 210000002640 perineum Anatomy 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001902 propagating effect Effects 0.000 description 1
- 238000011471 prostatectomy Methods 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 239000003642 reactive oxygen metabolite Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 229930187593 rose bengal Natural products 0.000 description 1
- 229940081623 rose bengal Drugs 0.000 description 1
- STRXNPAVPKGJQR-UHFFFAOYSA-N rose bengal A Natural products O1C(=O)C(C(=CC=C2Cl)Cl)=C2C21C1=CC(I)=C(O)C(I)=C1OC1=C(I)C(O)=C(I)C=C21 STRXNPAVPKGJQR-UHFFFAOYSA-N 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000007761 synergistic anti-cancer Effects 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 238000000015 thermotherapy Methods 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 210000000626 ureter Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000001018 xanthene dye Substances 0.000 description 1
- 229940072358 xylocaine Drugs 0.000 description 1
Images
Landscapes
- Surgical Instruments (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000203058A JP4454114B2 (ja) | 2000-06-30 | 2000-06-30 | 超音波治療装置 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000203058A JP4454114B2 (ja) | 2000-06-30 | 2000-06-30 | 超音波治療装置 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007124024A Division JP4459979B2 (ja) | 2007-05-09 | 2007-05-09 | 超音波治療装置 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2002017742A JP2002017742A (ja) | 2002-01-22 |
| JP2002017742A5 JP2002017742A5 (https=) | 2005-07-14 |
| JP4454114B2 true JP4454114B2 (ja) | 2010-04-21 |
Family
ID=18700506
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000203058A Expired - Fee Related JP4454114B2 (ja) | 2000-06-30 | 2000-06-30 | 超音波治療装置 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP4454114B2 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7967763B2 (en) * | 2005-09-07 | 2011-06-28 | Cabochon Aesthetics, Inc. | Method for treating subcutaneous tissues |
| US10548659B2 (en) | 2006-01-17 | 2020-02-04 | Ulthera, Inc. | High pressure pre-burst for improved fluid delivery |
| US8518069B2 (en) | 2005-09-07 | 2013-08-27 | Cabochon Aesthetics, Inc. | Dissection handpiece and method for reducing the appearance of cellulite |
| US9011473B2 (en) | 2005-09-07 | 2015-04-21 | Ulthera, Inc. | Dissection handpiece and method for reducing the appearance of cellulite |
| US9486274B2 (en) | 2005-09-07 | 2016-11-08 | Ulthera, Inc. | Dissection handpiece and method for reducing the appearance of cellulite |
| US9358033B2 (en) | 2005-09-07 | 2016-06-07 | Ulthera, Inc. | Fluid-jet dissection system and method for reducing the appearance of cellulite |
| US20070060989A1 (en) * | 2005-09-07 | 2007-03-15 | Deem Mark E | Apparatus and method for disrupting subcutaneous structures |
| US8439940B2 (en) | 2010-12-22 | 2013-05-14 | Cabochon Aesthetics, Inc. | Dissection handpiece with aspiration means for reducing the appearance of cellulite |
| US10058718B2 (en) | 2009-03-02 | 2018-08-28 | Koninklijke Philips N.V. | Transurethral ultrasound probe for treatment of prostate |
| US11096708B2 (en) | 2009-08-07 | 2021-08-24 | Ulthera, Inc. | Devices and methods for performing subcutaneous surgery |
| US9358064B2 (en) | 2009-08-07 | 2016-06-07 | Ulthera, Inc. | Handpiece and methods for performing subcutaneous surgery |
| CN113520586B (zh) * | 2021-07-16 | 2022-06-17 | 河南科技大学第一附属医院 | 一种穿刺灌注针、灌注件及肿瘤射频消融电极头 |
| CN113520585B (zh) * | 2021-07-16 | 2022-06-17 | 河南科技大学第一附属医院 | 一种隔离灌注件、消融电极头以及肿瘤射频消融治疗装置 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2659790B2 (ja) * | 1989-03-13 | 1997-09-30 | オリンパス光学工業株式会社 | 腫瘍治療装置 |
| JP3373602B2 (ja) * | 1993-08-05 | 2003-02-04 | 株式会社東芝 | 超音波治療装置 |
| DE4310924C2 (de) * | 1993-04-02 | 1995-01-26 | Siemens Ag | Therapieeinrichtung zur Behandlung von pathologischem Gewebe mit Ultraschallwellen und einem Katheder |
| US5558092A (en) * | 1995-06-06 | 1996-09-24 | Imarx Pharmaceutical Corp. | Methods and apparatus for performing diagnostic and therapeutic ultrasound simultaneously |
| WO1998001131A1 (en) * | 1996-07-05 | 1998-01-15 | Hitachi, Ltd. | Drugs inducing ultrasonic action and apparatus wherein the drugs are used |
| JP4095729B2 (ja) * | 1998-10-26 | 2008-06-04 | 株式会社日立製作所 | 治療用超音波装置 |
-
2000
- 2000-06-30 JP JP2000203058A patent/JP4454114B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP2002017742A (ja) | 2002-01-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Alphandéry | Ultrasound and nanomaterial: an efficient pair to fight cancer | |
| US7686763B2 (en) | Use of contrast agents to increase the effectiveness of high intensity focused ultrasound therapy | |
| US7722539B2 (en) | Treatment of unwanted tissue by the selective destruction of vasculature providing nutrients to the tissue | |
| CA2190237C (en) | Apparatus and method for transurethral focussed ultrasound therapy | |
| US7070565B2 (en) | Solid hydrogel coupling for ultrasound imaging and therapy | |
| US6723064B2 (en) | Ultrasonic catheter drug delivery method and device | |
| EP1711109B1 (en) | Localized production of microbubbles and control of cavitational and heating effects by use of enhanced ultrasound | |
| JP3930052B2 (ja) | カテーテルに基づく手術 | |
| JP4454114B2 (ja) | 超音波治療装置 | |
| JP2003033365A (ja) | 超音波治療装置 | |
| US20070088345A1 (en) | Applications of HIFU and chemotherapy | |
| JP4686269B2 (ja) | 超音波治療装置 | |
| JP2009506870A (ja) | 皮下組織を治療する方法 | |
| JP4459979B2 (ja) | 超音波治療装置 | |
| KR20250036050A (ko) | 표적 조직 치료를 위한 시스템, 장치 및 방법 | |
| US20070123780A1 (en) | Low-frequency focus ultrasound-generating device for tumor treatment using ultrasound irradiation microbubble agent | |
| Izadifar et al. | Applications and safety of therapeutic ultrasound: Current trends and future potential | |
| WO2006030534A1 (en) | Integrated system for noninvasive focused energy treatment using energy activated drugs | |
| EP1020180A2 (en) | Biocompatible, injectable aqueous solution for use in ultrasound energy assisted surgery | |
| RU2158619C2 (ru) | Способ консервативного лечения доброкачественной гиперплазии предстательной железы | |
| Izadifar | VISUALIZATION OF ULTRASOUND INDUCED CAVITATION BUBBLES USING SYNCHROTRON ANALYZER BASED IMAGING | |
| Swamy | Ultrasound for BP measurement and treatment in subjects with resistant hypertension | |
| JPH09202736A (ja) | 止血剤 | |
| US20040082936A1 (en) | Biocompatible, injectable aqueous solution for use in ultrasound energy assisted surgery | |
| Martin et al. | Therapeutic potential and consideration of high intensity ultrasound in gastroenterology |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20041119 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20041119 |
|
| RD02 | Notification of acceptance of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7422 Effective date: 20060628 |
|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20060628 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20060816 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20060822 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20061023 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20070313 |
|
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20070426 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070509 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20070501 |
|
| A911 | Transfer of reconsideration by examiner before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20070604 |
|
| A912 | Removal of reconsideration by examiner before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A912 Effective date: 20070907 |
|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20090610 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20091204 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20100202 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130212 Year of fee payment: 3 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140212 Year of fee payment: 4 |
|
| LAPS | Cancellation because of no payment of annual fees |